Immunovant COO Melanie Gloria sells 17,714 shares in 2 transactions for $678,604.34 at $38.31 average
Melanie Gloria, Chief Operating Officer of Immunovant, Inc., executed two separate sales on 2026-06-26 totaling 17,714 shares for $678,604.34, reducing her post-transaction holdings to 224,393 shares (a net reduction of 7.3% from pre-transaction levels of 242,107 shares). The blended average sale price of $38.31 sits near the current price of $38.85 and within 1.1% of the 52-week high of $39.28, suggesting the sales occurred at elevated levels relative to the stock's recent trading range. The company reported a full-year net loss of $110,635,000.00 and maintains a negative net income position, which provides material context for executive equity disposition activity at a profitable stock price. The reduction in holdings during a period of significant recent upside (30-day change of +16.3% and 90-day change of +62.0%) is the pattern requiring investor awareness in light of the company's unprofitability.